It is a pharma private limited company based in Solapur, Maharashtra, India, established in 1997.
1997 | Solapur, Maharashtra, India | ActiveRasayan Drugs Private Limited, a active private limited company, was established on 03 November 1997 in Solapur, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U99999PN1997PTC111662. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.23 Cr.
It upholds a compliant status. Employing 26 professional, Its leadership includes Nehru Veeraraghavarao Yanamadala (Director), Madhur Nehru Yanamadala (Director). Past directors included Prameela Nehru Yanamadala, Madhur Nehru Yanamadala. It holds ₹2.56 Cr open charges and ₹5.85 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-22/2, At Post Kondi, Chincholi Kati, Mohol, North Solapur, Solapur, Maharashtra, 441300.
U99999PN1997PTC111662
111662
03 November 1997
₹1.25 Cr
₹1.23 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Rasayan Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nehru Veeraraghavarao Yanamadala | Director | 01 Sep 2001 | Current |
| Madhur Nehru Yanamadala | Director | 26 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rasayan Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.57% decrease. The company also saw a substantial fall in profitability, with a 37.41% decrease in profit. The company's net worth moved up by a moderate rise of 2.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rasayan Drugs had a promoter holding of 24.72% and a public holding of 75.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,600,000.00
₹58,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jun 2020 | State Bank Of India | ₹2.56 Cr | Open |
| 12 Jul 2018 | Hdfc Bank Limited | ₹2.30 Cr | Satisfied |
| 21 Jul 2017 | Hdfc Bank Limited | ₹1.50 Cr | Satisfied |
| 04 Sep 2015 | Hdfc Bank Limited | ₹1.00 Cr | Satisfied |
| 09 Feb 2007 | Icici Bank Limited | ₹0.52 M | Satisfied |
Explore comprehensive loan charge details -
Rasayan Drugs has a workforce of 26 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rasayan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasayan Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rasayan Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Rasayan Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge registered on 21 Jul 2017 via Charge ID 100125391 with Hdfc Bank Limited was fully satisfied on 10 Feb 2021. was documented.
Progress on A charge registered on 04 Sep 2015 via Charge ID 10596088 with Hdfc Bank Limited was fully satisfied on 10 Feb 2021. was documented.
A charge with State Bank Of India amounted to Rs. 2.56 Cr with Charge ID 100355060 was registered on 12 Jun 2020. was recorded as a recent event.
Progress on A charge registered on 12 Jul 2018 via Charge ID 100260314 with Hdfc Bank Limited was fully satisfied on 03 Jun 2019. was documented.
The CIN of Rasayan Drugs Private Limited is U99999PN1997PTC111662.
Rasayan Drugs Private Limited is headquartered at A-22/2, At Post Kondi, Chincholi Kati, Mohol, North Solapur, Solapur, Maharashtra, 441300.
Rasayan Drugs Private Limited was incorporated on 03 November 1997.
The current directors of Rasayan Drugs Private Limited are
The primary industry of Rasayan Drugs Private Limited is Manufacturing.
Rasayan Drugs Private Limited is unlisted.
The authorized capital of Rasayan Drugs Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.23 Cr.
The compliance status of Rasayan Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX